AlphAIalphai — Financial news for AI agents
marketbeat.comJUL 254 min read$SHOO

Principal Financial Group Inc. Cuts Stock Position in Steven Madden, Ltd. $SHOO

Principal Financial Group cut its Steven Madden (NASDAQ:SHOO) stake by 25.1% in Q1, selling 118,293 shares to hold 353,332 shares, worth about $11.99M (0.48%). The article also cites recent insider sales and analyst price targets, with SHOO trading around $42.75 and reporting Q1 EPS of $0.45 on $653.1M revenue.

Original reporting
marketbeat.com
Published Jul 25, 2026, 9:18 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 25, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Principal Financial Group Inc. Cuts Stock Position in Steven Madden, Ltd. $SHOO — source image
Source · marketbeat.com
Decision brief

The 30-second read

$SHOONeutralLow
01

Why it matters

For traders, the actionable takeaway is mainly sentiment and positioning, not a new fundamental driver. SHOO’s near-term trading should still be dominated by earnings/guidance, macro demand for discretionary apparel, and any subsequent institutional flows.

02

Market read

Institutional ownership trimming by a large holder can influence short-term sentiment, but the article lacks new company-specific fundamentals or a fresh catalyst.

03

What to watch

The article mixes 13F ownership changes with insider sales and analyst PTs; without context on Principal’s total portfolio or mandate, the signal-to-noise for SHOO is low.

Relevance 4/10Novelty 4/10Timing: based on Q1 SEC filing; not tied to an immediate catalyst

Background

The piece summarizes Principal Financial Group’s Q1 SEC filing showing a reduced position in Steven Madden, alongside other institutional activity and insider sales.

Company-level read

Ticker impact

$SHOONeutralMedium confidence
Context

Principal Financial Group cut its SHOO stake by 25.1% in Q1, leaving 353,332 shares after selling 118,293.

Expected impact

Likely limited near-term impact; any effect should be modest unless followed by additional selling or new company-specific catalysts.

Evidence & confidence

The only disclosed SHOO-specific change is a 13F-style position reduction by one institution, plus routine insider sales and analyst target updates, without new earnings, guidance, or operational developments.

Market effects

Sector

No direct sector catalyst; only a fashion footwear name’s institutional ownership change.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The trim may be portfolio rebalancing or risk management rather than a bearish view on SHOO fundamentals, especially since other funds reportedly increased positions.

Key entities

  • equity
    Steven Madden, Ltd.

    NASDAQ-listed fashion footwear and accessories company referenced as the recipient of institutional ownership changes.

  • institutional_investor
    Principal Financial Group Inc.

    Institution that reduced its SHOO holdings by 25.1% during Q1 per its SEC filing.

Read at source← All news

Related articles

AUG 1
$SHOOMed

Steven Madden, Ltd. Q2 2026 Earnings Call Summary

Steven Madden (SHOO) reported Q2 2026 revenue up 19%, citing strong Steve Madden demand and Kurt Geiger integration. Wholesale gross margin rose to 35.2%. Full-year revenue guidance was raised to 11% to 13% growth, and EPS guidance adjusted for freight headwinds tied to Middle East conflict. Company also received $92.1M tariff refunds and expects private label declines.

yahoo.com6 min
JUL 31
$SHOOHighAI 9/10

Steven Madden (SHOO) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Edward Rosenfeld Chief Financial Officer and Executive Vice President of Operations - Zine Mazouzi Vice President of Corporate Development and Investor Relations - Danielle McCoy TAKEAWAYS Consolidated Revenue -- $665.9 million, an increase of 19.1% year over year driven by the acquisition of Kurt Geiger and organic growth in the Steve Madden and Dolce Vita brands.

fool.com6 min
JUL 30
$SHOOHighAI 9/10

Steve Madden Is on the Upswing as Company Delivers Strong Q2

Steven Madden (Steven Madden Ltd.) reported Q2 ended June 30 net income of $27.7M, or 38 cents diluted EPS, versus a year-ago net loss. Revenue rose 19.1% to $665.9M and net sales rose 19.2% to $662.9M. DTC revenue increased 30.6% to $255.4M. The company raised FY2026 revenue guidance to +11% to +13% and adjusted diluted EPS to $2.05-$2.15.

wwd.com6 min
JUL 30
$SHOOHigh

STEVEN MADDEN, LTD. (SHOO): Results of Operations and Financial Condition

STEVEN MADDEN, LTD. (SHOO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Steve Madden Announces Second Quarter 2026 Results ~ Raises Fiscal 2026 Revenue and Adjusted Diluted EPS Guidance; Reaffirms GAAP Diluted EPS Guidance ~ ~ Announces Appointment of Ken Pilot to Board of Directors ~ LONG ISLAND CITY, N.Y., July 30, 2026 – Steven Madden

SEC EDGAR 8-K6 min
SEP 8
$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

yahoo.com3 min